tiprankstipranks
Trending News
More News >
Chemung Financial (CHMG)
NASDAQ:CHMG
US Market

Chemung Financial (CHMG) AI Stock Analysis

Compare
110 Followers

Top Page

CH

Chemung Financial

(NASDAQ:CHMG)

Rating:71Outperform
Price Target:
$52.00
▲(4.21%Upside)
Chemung Financial's overall stock score is supported by its strong valuation metrics and solid financial performance, despite some pressure on profitability margins and cash flow volatility. The corporate events suggest strategic direction but introduce short-term uncertainties.

Chemung Financial (CHMG) vs. SPDR S&P 500 ETF (SPY)

Chemung Financial Business Overview & Revenue Model

Company DescriptionChemung Financial Corporation operates as the holding company for Chemung Canal Trust Company that provides a range of banking, financing, fiduciary, and other financial services. The company provides demand, savings, and time deposits; non-interest and interest-bearing checking accounts; and insured money market accounts. It also offers commercial and agricultural loans comprising loans to small to mid-sized businesses; commercial mortgage loans; residential mortgage loans; consumer loans, including home equity lines of credit and home equity term loans; and interest rate swaps, letters of credit, wealth management, employee benefit plans, mutual fund, insurance products, and brokerage services. Further, it provides securities, insurance, and tax preparation services. Additionally, it offers guardian, custodian, and trustee services, as well as acts as an agent for pension, profit-sharing, and other employee benefit trusts; and various investment, pension, estate planning, and employee benefit administrative services. The company operates 31 branch offices located in 13 counties in New York and Bradford County in Pennsylvania. Chemung Financial Corporation was founded in 1833 and is headquartered in Elmira, New York.
How the Company Makes MoneyChemung Financial makes money primarily through interest and non-interest income. Interest income is generated through the company's core banking operations, which include offering loans and mortgages to individuals and businesses. The interest charged on these loans is a primary revenue stream. Additionally, Chemung Financial earns money from the interest on securities held in its investment portfolio. Non-interest income is generated through various banking services, including fees from deposit accounts, trust and wealth management services, and other financial products. The company's revenue is also influenced by partnerships with other financial institutions, which can enhance service offerings and expand market reach. Key factors contributing to its earnings include the overall interest rate environment, the economic conditions in its service areas, and its ability to attract and retain customers.

Chemung Financial Financial Statement Overview

Summary
Overall, Chemung Financial demonstrates robust financial health with consistent revenue growth and profitability. The company's balance sheet is solid, with declining debt levels and strong equity. Cash flow management appears effective, though recent operating cash flow reductions require attention. Continued focus on maintaining asset growth and cash flow stability will be crucial for future performance.
Income Statement
65
Positive
Chemung Financial has shown consistent revenue growth, with a healthy net profit margin averaging around 26% over the years. The gross profit margin appears strong, although EBIT and EBITDA margins have fluctuated. The company experienced a slight decline in net income in the most recent year, which slightly impacts the overall income statement score.
Balance Sheet
72
Positive
The balance sheet reflects a solid equity position with stockholders' equity increasing over time. A significant reduction in total debt is positive, enhancing the debt-to-equity ratio. The equity ratio shows stability, indicating a strong financial foundation. However, the recent decrease in total assets may need monitoring.
Cash Flow
68
Positive
Chemung Financial maintains a positive operating cash flow, although it decreased significantly in the last year, which is a concern. The free cash flow to net income ratio indicates efficient cash generation relative to earnings. However, fluctuations in investing cash flow highlight potential volatility in capital management.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue96.11M95.74M94.61M88.42M82.87M
Gross Profit96.11M95.74M94.61M88.42M82.87M
EBITDA0.0034.30M39.91M37.26M28.13M
Net Income23.67M25.00M28.78M26.43M19.26M
Balance Sheet
Total Assets2.78B2.71B2.65B2.42B2.28B
Cash, Cash Equivalents and Short-Term Investments591.64M630.17M688.46M819.01M663.15M
Total Debt118.52M40.80M201.57M25.86M11.11M
Total Liabilities2.56B2.52B2.48B2.21B2.08B
Stockholders Equity215.31M195.24M166.39M211.46M199.70M
Cash Flow
Free Cash Flow26.19M30.42M34.62M35.09M27.79M
Operating Cash Flow29.82M30.88M35.05M35.46M28.66M
Investing Cash Flow-57.72M-82.38M-252.62M-242.48M-495.85M
Financing Cash Flow38.10M32.48M246.46M125.47M453.82M

Chemung Financial Technical Analysis

Technical Analysis Sentiment
Positive
Last Price49.90
Price Trends
50DMA
46.53
Positive
100DMA
46.99
Positive
200DMA
47.68
Positive
Market Momentum
MACD
0.74
Negative
RSI
64.54
Neutral
STOCH
90.74
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CHMG, the sentiment is Positive. The current price of 49.9 is above the 20-day moving average (MA) of 47.45, above the 50-day MA of 46.53, and above the 200-day MA of 47.68, indicating a bullish trend. The MACD of 0.74 indicates Negative momentum. The RSI at 64.54 is Neutral, neither overbought nor oversold. The STOCH value of 90.74 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CHMG.

Chemung Financial Risk Analysis

Chemung Financial disclosed 39 risk factors in its most recent earnings report. Chemung Financial reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Chemung Financial Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$249.22M15.417.72%2.72%8.36%-2.51%
78
Outperform
$215.63M13.336.54%5.78%24.45%25.55%
71
Outperform
$239.06M10.5310.65%2.56%6.05%-9.27%
70
Outperform
$241.07M11.3410.50%4.04%14.11%29.41%
61
Neutral
C$14.56B6.1620.17%5.70%26.93%-38.21%
60
Neutral
$220.08M18.326.62%3.34%-6.85%-51.70%
56
Neutral
$272.94M68.831.06%3.62%5.36%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CHMG
Chemung Financial
49.90
6.49
14.95%
EVBN
Evans Bancorp
39.53
12.81
47.94%
LCNB
LCNB
15.22
2.87
23.24%
PWOD
Penns Woods Bancorp
31.66
12.93
69.03%
FRST
Primis Financial
11.04
1.04
10.40%
MBCN
Middlefield Banc
30.84
9.56
44.92%

Chemung Financial Corporate Events

Business Operations and StrategyFinancial Disclosures
Chemung Financial Completes Strategic Balance Sheet Repositioning
Negative
Jun 12, 2025

Chemung Financial Corporation announced the completion of a strategic balance sheet repositioning by selling securities worth approximately $242 million, resulting in a pre-tax loss of $17 million to be recognized in the second quarter of 2025. The proceeds will be used to reduce non-core funding liabilities and support loan growth, with expectations of improved financial metrics from the third quarter of 2025, despite reporting a net loss for the second quarter.

The most recent analyst rating on (CHMG) stock is a Hold with a $57.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.

Private Placements and FinancingBusiness Operations and Strategy
Chemung Financial Issues $45M Subordinated Notes
Positive
Jun 10, 2025

On June 10, 2025, Chemung Financial Corporation issued $45 million in subordinated notes due 2035 to accredited investors and institutional buyers. This move aims to support the company’s growth initiatives and regulatory capital ratios, potentially involving balance sheet restructuring. The notes, maturing in 2035, will initially bear a fixed interest rate of 7.75% until 2030, after which they will switch to a floating rate. This strategic financial maneuver is expected to enhance Chemung’s capital structure and support its expansion efforts.

The most recent analyst rating on (CHMG) stock is a Hold with a $57.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.

Executive/Board ChangesShareholder Meetings
Chemung Financial Shareholders Approve Key Proposals at Meeting
Neutral
Jun 3, 2025

At the Annual Meeting of Shareholders on June 3, 2025, Chemung Financial Corporation shareholders voted on four proposals. The election of directors resulted in the appointment of Ronald M. Bentley, David M. Buicko, Robert H. Dalrymple, and Jeffrey B. Streeter for three-year terms. Additionally, the shareholders approved the compensation for the Corporation’s Named Executive Officers, the 2025 Equity Incentive Plan, and ratified the appointment of Crowe LLP as the independent registered public accounting firm for the year ending December 31, 2025.

The most recent analyst rating on (CHMG) stock is a Hold with a $57.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.

Dividends
Chemung Financial Declares Quarterly Cash Dividend
Positive
May 22, 2025

On May 22, 2025, Chemung Financial Corporation announced a quarterly cash dividend of $0.32 per share, payable on July 1, 2025, to shareholders of record as of June 17, 2025. This decision reflects the company’s ongoing commitment to providing value to its shareholders and may positively impact its market positioning by reinforcing investor confidence.

The most recent analyst rating on (CHMG) stock is a Hold with a $57.00 price target. To see the full list of analyst forecasts on Chemung Financial stock, see the CHMG Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 22, 2025